Skip to content

TTRX TTRX Common Stock

Common Stock at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$10.54B+0.3%
PTH
Pelthos Therapeutics Inc.PTHS
200M+32,206,019%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$67K+1.5%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
300M0.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$8K+14.3%
PVL
Palvella TherapeuticsPVLA
$14K+27.3%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's common stock?
TTRX (TTRX) reported common stock of $500M in Q1 2026.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).